No specific host molecular drug target

The designation "No specific host molecular drug target" refers to a category of pharmacological agents that exert their therapeutic effects without binding to a specific host protein, such as a receptor, enzyme, or transporter (ChEMBL Database). These agents typically function through direct chemical reactions or physical processes. For instance, antacids like aluminum hydroxide work by chemically neutralizing hydrochloric acid in the stomach (StatPearls, "Antacids", 2023). Osmotic laxatives, such as polyethylene glycol, create an osmotic gradient to retain water in the intestinal lumen, thereby increasing stool volume and frequency (PubMed, PMID: 21848466). Additionally, chelating agents like edetate calcium disodium bind to heavy metal ions to facilitate their renal excretion, while adsorbents like activated charcoal physically trap toxins to prevent gastrointestinal absorption (NIH, LiverTox; WHO Model Formulary). Because these substances do not rely on high-affinity interactions with biological signaling pathways, they are classified as having no specific host molecular target in drug databases to distinguish them from traditional targeted therapies.

Other names

Non-molecular targetNon-specific host targetPhysical/Chemical mechanism of actionNo host target

Therapeutic effect is achieved through non-specific physical or chemical interactions, such as the neutralization of gastric acid, the creation of osmotic gradients, or the physical adsorption of substances, rather than binding to a host macromolecule (StatPearls, "Pharmacodynamics", 2023).